DSpace Repository

Astana experience: department of oncohematology and bone marrow transplantation, National Research Center of Oncology and Transplantation

Show simple item record

dc.contributor.author Kemaikin, Vadim M.
dc.contributor.author Olifirovich, Anastasiya A.
dc.contributor.author Kolesnev, Alexandr V.
dc.contributor.author Nemerovchenko, Anatoliy V.
dc.contributor.author Vildanova, Ruzal F.
dc.contributor.author Gainutdinova, Olga V.
dc.contributor.author Tusipova, Adiya A.
dc.contributor.author Esimbekova, Ayauzhan E.
dc.contributor.author Baimursina, Aliya K.
dc.contributor.author Suleimenova, Ayzat S.
dc.contributor.author Lesechko, Olga O.
dc.contributor.author Ansatbaeva, Gulnaz D.
dc.contributor.author Alimbetova, Mariya S
dc.date.accessioned 2018-06-07T09:30:01Z
dc.date.available 2018-06-07T09:30:01Z
dc.date.issued 2017
dc.identifier.citation Kemaikin, Vadim M., Olifirovich, Anastasiya A., Kolesnev, Alexandr V., Nemerovchenko, Anatoliy V., Vildanova, Ruzal F., Gainutdinova, Olga V., Tusipova, Adiya A.,  Esimbekova, Ayauzhan E., Baimursina, Aliya K., Suleimenova, Ayzat S., Lesechko, Olga O.,  Ansatbaeva, Gulnaz D., Alimbetova, Mariya S.. ( 2017) Astana experience: Department of Oncohematology and Bone Marrow Transplantation, National Research Center of Oncology and Transplantation. Cellular Therapy and Transplantation (CTT). Vol. 6, No. 1 (18) en_US
dc.identifier.uri doi: 10.18620/ctt-1866-8836-2017-6-1-30-36
dc.identifier.uri http://nur.nu.edu.kz/handle/123456789/3332
dc.description.abstract The Unit of Oncohematology and Bone Marrow Transplantation (BMT) was arranged on basis of the Republican Research Center of Hospital Emergencies SC (Astana, Republic of Kazakhstan) in August 2010. Since July 2014, a Clinical Department with 69 beds was arranged, and National Research Center for Oncology and Transplantation SC was arranged. From 2010 to 2016, the modalities of hematopoietic stem cell transplantation have been advanced, from autologous BMT to allogeneic hematopoietic stem cell transplants (HSCT) from matched donors (33%), and haploidentical HSCTs (43% in 2016), a total of 186 transpants. Bone marrow was used as a source of stem cells in 71 cases (71 donors for allo-HSCT in 69 recipients), whereas peripheral stem cells were harvested in 73 cases (15 donors for 15 recipients of allo-BMT, and 58 marrow harvests for autologous BMT). en_US
dc.language.iso en en_US
dc.publisher Cellular Therapy and Transplantation (CTT). en_US
dc.rights Attribution-NonCommercial-ShareAlike 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/us/ *
dc.subject Hematopoietic stem cell transplantation, clinical advancements, Astana, Republic of Kazakhstan. en_US
dc.title Astana experience: department of oncohematology and bone marrow transplantation, National Research Center of Oncology and Transplantation en_US
dc.type Article en_US
workflow.import.source science


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States